FGFR2 and cancer: This included the following: a missense mutation in CDH1 (D254Y) that has been described in three other cancers; a missense mutation (L130F) in TP53 where mutations in this codon have been reported in 37 other cancers; the FGFR2 amplification which we and others have identified in diffuse gastric cancer.